Details for Patent: 11,083,733

« Back to Dashboard

Which drugs does patent 11,083,733 protect, and when does it expire?

Patent 11,083,733 protects FILSUVEZ and is included in one NDA.

This patent has twenty patent family members in fourteen countries.

Summary for Patent: 11,083,733

Title:	Betulin-containing birch bark extracts and their formulation
Abstract:	The present disclosure relates to birch bark extracts, methods of producing such extracts, stable pharmaceutical compositions containing such extracts and methods of using of such extracts. The birch bark extracts of the present disclosure contain triterpenes, which are known to improve wound healing.
Inventor(s):	John Ashleigh Watson, Sebastian Jäger, Tobias Zahn
Assignee:	Amryt Pharmaceuticals Designated Activity Co
Application Number:	US17/120,678
Patent Claim Types: see list of patent claims	Process;

Drugs Protected by US Patent 11,083,733

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Chiesi	FILSUVEZ	birch triterpenes	GEL;TOPICAL	215064-001	Dec 18, 2023		RX	Yes	Yes			Y

International Family Members for US Patent 11,083,733

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2019205091
Brazil	112020009867
Canada	3081624